Rather, our extended data analysis using genomic, epigenetic, and transcriptomic profiles integrated into our bioinformatics framework determined potential functional consequences of the p53-effector lncRNAs in hundreds of cancer cells and thousands of patient samples across 10 different cancer types. The gene discussed is TP53; the disease is cancer.